EA200100405A1 - Применение 3-(1н-имидазол-4-илметил)индан-5-ола при изготовлении лекарственного средства для интраспинального, подоболочечного или эпидурального введения - Google Patents
Применение 3-(1н-имидазол-4-илметил)индан-5-ола при изготовлении лекарственного средства для интраспинального, подоболочечного или эпидурального введенияInfo
- Publication number
- EA200100405A1 EA200100405A1 EA200100405A EA200100405A EA200100405A1 EA 200100405 A1 EA200100405 A1 EA 200100405A1 EA 200100405 A EA200100405 A EA 200100405A EA 200100405 A EA200100405 A EA 200100405A EA 200100405 A1 EA200100405 A1 EA 200100405A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- indan
- imidazol
- intraspinal
- ilmethil
- ola
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- VTZPAJGVRWKMAG-UHFFFAOYSA-N 3-(1h-imidazol-5-ylmethyl)-2,3-dihydro-1h-inden-5-ol Chemical compound C12=CC(O)=CC=C2CCC1CC1=CN=CN1 VTZPAJGVRWKMAG-UHFFFAOYSA-N 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 2
- 230000036592 analgesia Effects 0.000 abstract 2
- 150000002148 esters Chemical class 0.000 abstract 2
- 230000001939 inductive effect Effects 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 206010002091 Anaesthesia Diseases 0.000 abstract 1
- 206010039897 Sedation Diseases 0.000 abstract 1
- 230000002411 adverse Effects 0.000 abstract 1
- 230000037005 anaesthesia Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000036280 sedation Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Настоящее изобретение относится к способу индуцирования аналгезии введением млекопитающему 3-(1H-имидазол-4-илметил) индан-5-ола, его энантиомера или его фармацевтически приемлемого сложного эфира или соли интраспинально. 3-(1H-Имидазол-4-илметил)индан-5-ол, его энантиомер или его фармацевтически приемлемый сложный эфир или соль можно вводить интраспинально млекопитающему, индуцируя аналгезию без побочных вредных эффектов, таких как седативный эффект. Настоящее изобретение относится также к способу использования данного лекарственного средства для анестезии введением интраспинально.Международная заявка была опубликована вместе с отчетом о международном поиске.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10198698P | 1998-09-28 | 1998-09-28 | |
| PCT/FI1999/000793 WO2000018400A1 (en) | 1998-09-28 | 1999-09-27 | Use of 3-(1h-imidazol-4-ylmethyl)-indan-5-ol in the manufacture of a medicament for intraspinal, intrathecal or epidural administration |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA200100405A1 true EA200100405A1 (ru) | 2001-10-22 |
| EA003216B1 EA003216B1 (ru) | 2003-02-27 |
Family
ID=22287519
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200100405A EA003216B1 (ru) | 1998-09-28 | 1999-09-27 | Применение 3-(1h-имидазол-4-илметил)индан-5-ола при изготовлении лекарственного средства для интраспинального, подоболочечного или эпидурального введения |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6495584B1 (ru) |
| EP (1) | EP1117399B1 (ru) |
| JP (1) | JP4647785B2 (ru) |
| KR (1) | KR100646811B1 (ru) |
| CN (1) | CN1320034A (ru) |
| AT (1) | ATE288753T1 (ru) |
| AU (1) | AU756104B2 (ru) |
| BG (1) | BG105469A (ru) |
| CA (1) | CA2345521C (ru) |
| CZ (1) | CZ299918B6 (ru) |
| DE (1) | DE69923698T2 (ru) |
| DK (1) | DK1117399T3 (ru) |
| EA (1) | EA003216B1 (ru) |
| EE (1) | EE200100193A (ru) |
| ES (1) | ES2237205T3 (ru) |
| HK (1) | HK1039751A1 (ru) |
| HU (1) | HU227634B1 (ru) |
| IL (2) | IL141680A0 (ru) |
| NO (1) | NO330436B1 (ru) |
| NZ (1) | NZ510233A (ru) |
| PL (1) | PL346908A1 (ru) |
| SK (1) | SK3812001A3 (ru) |
| UA (1) | UA61152C2 (ru) |
| WO (1) | WO2000018400A1 (ru) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001000192A2 (en) * | 1999-06-25 | 2001-01-04 | Orion Corporation | Method of administering an imidazole derivative to obtain analgesia |
| FI20022159A0 (fi) * | 2002-12-05 | 2002-12-05 | Orion Corp | Uusia farmaseuttisia yhdisteitä |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI894911A0 (fi) | 1989-10-17 | 1989-10-17 | Farmos Oy | En terapeutiskt vaerdefull foerening. |
| GB9520150D0 (en) | 1995-10-03 | 1995-12-06 | Orion Yhtymae Oy | New imidazole derivatives |
| US5801188A (en) * | 1997-01-08 | 1998-09-01 | Medtronic Inc. | Clonidine therapy enhancement |
-
1999
- 1999-09-27 EA EA200100405A patent/EA003216B1/ru not_active IP Right Cessation
- 1999-09-27 EE EEP200100193A patent/EE200100193A/xx unknown
- 1999-09-27 IL IL14168099A patent/IL141680A0/xx active IP Right Grant
- 1999-09-27 PL PL99346908A patent/PL346908A1/xx not_active Application Discontinuation
- 1999-09-27 CA CA002345521A patent/CA2345521C/en not_active Expired - Lifetime
- 1999-09-27 DK DK99969677T patent/DK1117399T3/da active
- 1999-09-27 US US09/787,886 patent/US6495584B1/en not_active Expired - Lifetime
- 1999-09-27 WO PCT/FI1999/000793 patent/WO2000018400A1/en active IP Right Grant
- 1999-09-27 ES ES99969677T patent/ES2237205T3/es not_active Expired - Lifetime
- 1999-09-27 DE DE69923698T patent/DE69923698T2/de not_active Expired - Lifetime
- 1999-09-27 CZ CZ20010933A patent/CZ299918B6/cs not_active IP Right Cessation
- 1999-09-27 CN CN99811480A patent/CN1320034A/zh active Pending
- 1999-09-27 SK SK381-2001A patent/SK3812001A3/sk unknown
- 1999-09-27 AT AT99969677T patent/ATE288753T1/de not_active IP Right Cessation
- 1999-09-27 NZ NZ510233A patent/NZ510233A/en not_active IP Right Cessation
- 1999-09-27 HU HU0103864A patent/HU227634B1/hu unknown
- 1999-09-27 AU AU59860/99A patent/AU756104B2/en not_active Expired
- 1999-09-27 KR KR1020017003511A patent/KR100646811B1/ko active IP Right Grant
- 1999-09-27 JP JP2000571918A patent/JP4647785B2/ja not_active Expired - Lifetime
- 1999-09-27 UA UA2001042926A patent/UA61152C2/uk unknown
- 1999-09-27 EP EP99969677A patent/EP1117399B1/en not_active Expired - Lifetime
-
2001
- 2001-02-27 IL IL141680A patent/IL141680A/en not_active IP Right Cessation
- 2001-03-26 NO NO20011545A patent/NO330436B1/no not_active IP Right Cessation
- 2001-04-25 BG BG105469A patent/BG105469A/xx unknown
-
2002
- 2002-02-22 HK HK02101329.8A patent/HK1039751A1/zh unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yeh et al. | Combination of opioid agonist and agonist–antagonist: patient-controlled analgesia requirement and adverse events among different-ratio morphine and nalbuphine admixtures for postoperative pain | |
| EA200500018A1 (ru) | Бензконденсированные гетероариламидные производные тиенопиридинов, применяемые в качестве терапевтических агентов, фармацевтические композиции, включающие их, и способы их применения | |
| EA200500088A1 (ru) | Трициклические модуляторы ядерного рецептора стероидного гормона | |
| EA200000718A1 (ru) | Композиции целекоксиба | |
| EA200801165A1 (ru) | Антагонисты неосновного рецептора-1 меланинконцентрирующего гормона | |
| HK1095139A1 (en) | Azabicyclic heterocycles as cannabinoid receptor modulators | |
| ECSP056182A (es) | Derivados de carbostirilo y estabilizantes del estado de ánimo para tratar trastornos del mismo | |
| BRPI0406883A (pt) | Composto, composição farmacêutica, método de tratar um distúrbio, e, uso de um composto | |
| BR9810841A (pt) | Inibidores de metaloprotease alicìclicos | |
| MX2007006637A (es) | Uso de atazanavir para mejorar los parametros farmacocineticos de farmacos metabolizados por isoforma 1a1 de udp-glucuronosil- transferasa. | |
| DE69628163D1 (de) | Nor-pregnane zur induzierung hypothalamischer effekte | |
| EP2281565A3 (en) | Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same | |
| EA200500985A1 (ru) | Твердая лекарственная форма для перорального применения | |
| MX2022008342A (es) | Metodos para tratar afecciones relacionadas con el receptor de s1p1. | |
| MX2022000430A (es) | Administracion de agonista de sting e inhibidores de puntos de control. | |
| EA200100405A1 (ru) | Применение 3-(1н-имидазол-4-илметил)индан-5-ола при изготовлении лекарственного средства для интраспинального, подоболочечного или эпидурального введения | |
| BR0114389A (pt) | Terapia antitumor que inclui derivado de distamicina | |
| WO1994016689A1 (en) | Analgesic medicinal composition | |
| KR910007523A (ko) | 과콜레스테린혈증, 과지방혈증 및 혈전색전증 질병 치료용 토코트리엔올 | |
| KR20050044396A (ko) | 정동 및 주의력 장애 및 신경병성 통증 치료용 의약제조에 사용하기 위한 모노히드록시카르바마제핀 | |
| TW200724138A (en) | Substituted carboxylic acid derivatives for the treatment of diabetes and lipid disorders, their preparation and use | |
| HUP9903679A2 (hu) | Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására | |
| EA201000832A1 (ru) | Замещённые 3-гидроксипиридины и содержащие их фармацевтические композиции | |
| EA200602199A1 (ru) | Композиции, содержащие глюкозаминогликан и нестероидное противовоспалительное средство | |
| SE9801516D0 (sv) | M100907/4-Piperidinemethanol derivatives for autism |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |